NPPES file of Aug 9, 2026

Esmilkrys Beatriz Ramirez, M.D.

Obesity Medicine (Preventive Medicine) Physician · Chicago, IL

Esmilkrys Beatriz Ramirez, M.D. is an obesity medicine (preventive medicine) physician with a practice address in Chicago, Illinois, and NPI 1083880546, issued on May 5, 2008. Check the license (Illinois 036125776, as entered in NPPES) on the Illinois Department of Financial and Professional Regulation; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1083880546
Name
Esmilkrys Beatriz Ramirez
Credential
M.D.
Primary taxonomy
Obesity Medicine (Preventive Medicine) Physician 2083B0002X
License number
036125776 IL
Self-reported in NPPES; status is on the state search
Practice location
4959 W Belmont Ave, Chicago, IL 60641
Phone
(773) 622-4400
Enumerated
May 5, 2008
Record last updated
Sep 23, 2021 (not updated in 5 years: call before relying on the address or phone)
Fax
(773) 622-4407
Medicaid ID
036125776 IL
Medicare enrollment
Enrolled (PECOS I20110414000940); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 4959 W Belmont Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. David Alameda, DPMFoot & Ankle Surgery Podiatrist1962408864
  2. Megha Patel, PA-CInternal Medicine Physician1962984773
  3. Noemi Villanueva, PAPhysician Assistant1649789967

Verify Esmilkrys Beatriz Ramirez in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersIllinois Department of Financial and Professional Regulation
    Search for license 036125776
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Illinois license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

3.6 times the Medicare Part D claims of the average obesity medicine (preventive medicine) physician in 2024

3,718 Medicare Part D claims for 476 beneficiaries, against an average of 1,045 among the 68 providers of this specialty who prescribed in Part D. Brand-name drugs were 26% of claims. 42 claims were for opioids.

  1. Esmilkrys Ramirez3,718
  2. Specialty average1,045

Most prescribed

  1. Atorvastatin Calcium202 claims
  2. Metformin Hcl158 claims
  3. Rosuvastatin Calcium116 claims
  4. Ozempic114 claims
  5. Levothyroxine Sodium98 claims
  6. Gabapentin96 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $2,506.52

95 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 40 providers of this specialty with any payment received $7,485.63 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Esmilkrys Ramirez$2,506.52
  2. Specialty average$7,485.63

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Obesity Medicine (Preventive Medicine) Physician providers in Illinois

There are 6 obesity medicine (preventive medicine) physician records in Illinois.

The 5 obesity medicine (preventive medicine) physician records with the nearest ZIP codes

  1. Finisa Rosenzweig, M.D.Chicago, IL 606571174781413
  2. Catherine Johnson, MD FACEP, ABOM, MSCPClarendon Hills, IL 605141083609218
  3. Manali Patel, MDBloomingdale, IL 601081770825853
  4. Darshan Patel, MDDeer Park, IL 600101376920264
  5. Lyndsay Hoffman, FNPArlington Heights, IL 600041518647593

Common questions

What is Esmilkrys Beatriz Ramirez, M.D.'s NPI number?

Esmilkrys Beatriz Ramirez, M.D.'s National Provider Identifier (NPI) is 1083880546, issued on May 5, 2008. An NPI identifies a provider in billing; it is not a license.

Where is Esmilkrys Beatriz Ramirez, M.D. located?

The NPPES record lists a practice address at 4959 W Belmont Ave, Chicago, IL, 60641. Phone: (773) 622-4400. Providers update this record themselves, so call before visiting.

How can I verify Esmilkrys Beatriz Ramirez, M.D.'s license?

NPPES lists Illinois license number 036125776, as entered by the provider. Search the Illinois Department of Financial and Professional Regulation at https://idfpr.illinois.gov/checklicense.html. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Esmilkrys Beatriz Ramirez, M.D. prescribe under Medicare Part D?

In 2024, Esmilkrys Beatriz Ramirez, M.D. had 3,718 Medicare Part D claims for 476 beneficiaries; the average among obesity medicine (preventive medicine) physician prescribers was 1,045. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.